Winkle College of Pharmacy Accreditation Affirmed
Accreditation is the hallmark of a colleges reputation, and the University of Cincinnatis James L. Winkle College of Pharmacy has cause to raise the banner high.
Thats because on Friday, Jan. 31, Dean Neil MacKinnon, PhD, received word from the Accreditation Council for Pharmacy Education (ACPE) that the colleges accreditation status had been affirmed for eight more years, extending through June 2022, which is the longest possible term granted by the ACPE.
The ACPE is the national agency for the accreditation of professional degree programs in pharmacy and providers of continuing pharmacy education.
The announcement comes after a rigorous process by which the college had to meet the ACPEs 30 standards of a quality pharmacy education. In preparation to meet these standards, faculty and staff began tackling an ACPE-required self-study two years ago.
The result was a 1,000-plus-page document submitted to the ACPE prior to a site visit in September 2013.
There were many areas identified as strengths by the on-site team as part of its assessment, says MacKinnon. In particular, he says, the ACPE team commented in a positive way about the quality and professionalism of our students and faculty, the ease in transition from the quarter to the semester system and the quality of the self-study document itself.
"The theme for our self-study was Good to Great! and Im proud that we conducted an honest self-evaluation, acted on areas targeted for improvement, and pushed our program to the next level. Its satisfying that the accreditation site team recognized this, remarked the colleges self-study chair, Associate Dean for Professional Education and Assessment Shauna Buring, PharmD.
Special recognition by the ACPE team was directed to the college preceptors and the quality of the experiential training program, she says. The college partners with 155 pharmacies in hospitals, nursing homes and communities to provide students with clinical experience.
"Over these past five months, Ive come to appreciate the quality and rigor of our PharmD program and the professionalism exhibited by our students, faculty, staff and preceptors, says MacKinnon, who came on board as dean in the midst of the accreditation process.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.